Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Warts × Tuberculin × Clear all

Phase

Status

Sponsor Class

OTHER 2 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Conditions

Interventions

human papillomavirus vaccine, L1 type 16, 18 1 Tuberculin 1 PRA1 protein, Candida albicans 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05254561 2022-02-24

Triple Antigen vs Monoantigen Immunotherapy for Warts

Zagazig University

Phase 2/3 Completed

Warts

Data powered by HemOnc (CC BY 4.0) Colophon ⚡